Africa is attracting unprecedented attention from international companies.

Consumer demand is expanding. Urbanisation is reshaping consumption. Digital commerce is opening new routes to market. Regional integration is creating opportunities for companies willing to think beyond individual national markets.

But there is a problem.

Many international companies enter Africa with a strategy that was designed somewhere else—and then discover that the strategy does not survive contact with the market.

The mistake is rarely a lack of capital or a weak product.

More often, it is a failure to understand how African markets actually work.

Africa is not a single market. It is a collection of national, regional and commercial ecosystems with different regulatory regimes, consumer behaviours, currencies, distribution structures, purchasing power, infrastructure, political environments and business cultures.

The World Bank’s latest work on African economic integration makes this point particularly clearly: even with the African Continental Free Trade Area (AfCFTA), customs systems, product standards, transport, payments, services and other commercial systems remain fragmented across borders.

For an international company, this means one thing:

Entering Africa is not simply a question of finding customers. It is a question of designing the right market-entry system.

Here are nine mistakes companies should avoid.

1. Treating Africa as One Market

Perhaps the most expensive strategic mistake is starting with the phrase:

“We want to enter Africa.”

Africa is a continent of more than 50 countries, not a single commercial territory.

The opportunity for a pharmaceutical company in Nigeria may look very different from the opportunity in Kenya. An FMCG proposition that works in South Africa may require substantial adaptation before it can succeed in Côte d’Ivoire or Cameroon.

Even neighbouring countries can have radically different:

• Regulatory requirements
• Consumer purchasing behaviour
• Distribution structures
• Import duties
• Currency risks
• Retail formats
• Payment practices
• Logistics costs
• Competitive landscapes

The right question is therefore not:

“How do we enter Africa?”

It is:

“Which African market should we enter first, with which product, through which route to market, and why?”

A strong Africa expansion strategy begins with market prioritisation, not geographical ambition.

2. Assuming That a Successful Product Will Automatically Succeed in Africa

International companies sometimes arrive with a product that has already performed exceptionally well in Europe, North America, Asia or the Middle East.

The assumption is understandable:

“The product works elsewhere, so there must be a market for it here.”

But product-market fit is not automatically transferable.

A product can be technically excellent and commercially unsuccessful because the price point, packaging, formulation, pack size, distribution model or positioning does not match local demand.

For FMCG companies, this can mean rethinking:

• Pack sizes
• Price points
• Product formats
• Flavours and formulations
• Packaging
• Brand communication
• Retail channels
• Promotional mechanics

For pharmaceutical companies, the considerations become even more complex, involving registration, clinical and technical requirements, local supply chains, pharmacovigilance, procurement systems and healthcare-provider behaviour.

The lesson is simple:

Do not ask whether Africans will buy your existing product. Ask what product configuration the target market is actually prepared to buy.

That distinction can completely change the business model.

3. Choosing a Distributor Because They Are “Well Connected”

This is one of the most common—and potentially dangerous—market-entry shortcuts.

An international company meets a local distributor who has an impressive network, knows government officials, has relationships with retailers and appears to know everybody.

The company signs an agreement.

Six months later, sales are disappointing.

Why?

Because connections are not the same thing as commercial capability.

A serious distributor assessment should examine much more than reputation.

International companies should investigate:

Commercial capability

• Existing product portfolio
• Sales-force size and structure
• Geographic coverage
• Key account relationships
• Route-to-market capabilities
• Customer concentration

Financial capability

• Working capital
• Credit capacity
• Payment history
• Inventory financing
• Foreign-exchange exposure

Operational capability

• Warehousing
• Cold-chain infrastructure where applicable
• Inventory management
• Logistics
• Regulatory capabilities
• Sales reporting

Strategic alignment

• Competing products
• Management commitment
• Growth ambitions
• Investment willingness
• Exclusivity expectations

The right question is not:

“Who can introduce us to people?”

It is:

“Who can consistently convert our product into revenue while protecting the brand and investing in the market?”

4. Underestimating Regulation

Regulation is not an administrative detail to be handled after the commercial strategy has been developed.

It can determine whether the commercial strategy is viable in the first place.

This is particularly important in pharmaceuticals, medical devices, food, cosmetics and other regulated categories.

Across Africa, regulatory systems are evolving, but significant differences remain between countries. In the health sector, WHO and the African Medicines Agency are actively working towards greater regulatory harmonisation, precisely because fragmented regulatory systems can delay access and increase complexity for companies.

For pharmaceutical companies, this means regulatory planning should begin before the market-entry decision is finalised.

Questions should include:

• What registrations are required?
• Who holds the marketing authorisation?
• What local representation is required?
• What are the import requirements?
• What are the labelling requirements?
• What pharmacovigilance obligations apply?
• How long can approval realistically take?
• What local manufacturing or sourcing expectations exist?
• How does public procurement operate?

WHO’s regional framework also highlights market fragmentation and insufficient market intelligence as challenges to sustainable pharmaceutical production and development in Africa.

Regulatory strategy should therefore be part of commercial strategy—not an afterthought.

5. Building a Business Model Around Unrealistic Pricing

An international company may calculate its African price by taking its global price and adding logistics, duties and distributor margins.

On paper, the calculation may look logical.

In the market, it may be completely wrong.

The issue is not simply whether consumers have money.

It is how they spend it.

African markets contain substantial differences in income, purchasing power and consumption behaviour. Consumers may be willing to spend significantly on certain categories while being extremely price-sensitive in others.

This makes value architecture critical.

Companies should consider:

• Entry-level SKUs
• Smaller pack sizes
• Tiered product portfolios
• Local pricing structures
• Distributor margins
• Retailer margins
• Taxes and duties
• Logistics costs
• Promotional discounts
• Currency volatility

A product can have excellent demand potential and still fail because the economics between manufacturer and final consumer do not work.

6. Ignoring the Reality of Distribution

Many international executives think of distribution as a simple sequence:

Manufacturer → Distributor → Retailer → Consumer

In many African markets, the reality is considerably more complex.

The route to market may involve multiple layers of wholesalers, sub-distributors, agents, informal retailers, pharmacies, modern trade, traditional trade and specialised channels.

The question is therefore not simply:

“Who will distribute our product?”

It is:

“How will the product physically and commercially reach the customer at the required cost, service level and speed?”

This is particularly important outside major commercial centres.

Infrastructure and cross-border trade remain significant considerations. The World Bank notes that African markets continue to face fragmentation in customs, transport, logistics, standards, payments and other systems.

For a company expanding across several countries, a sophisticated route-to-market architecture can become a competitive advantage in itself.

7. Assuming the First Country Must Be the Biggest Country

The biggest market is not automatically the best market for market entry.

This is particularly relevant to international companies looking at countries such as Nigeria, Egypt, South Africa, Kenya or Ethiopia.

Market size matters.

But so do:

• Regulatory accessibility
• Competitive intensity
• Distribution maturity
• Consumer fit
• Import conditions
• Currency stability
• Local partner availability
• Manufacturing ecosystem
• Regional export potential

Sometimes the better strategy is to establish a successful position in a smaller or more accessible market and use it as a regional platform.

This is where regional economic communities and AfCFTA become strategically important.

The objective should not always be:

“Where is the largest market?”

It should be:

“Where can we build the strongest and most scalable commercial position?”

8. Believing That a Strong International Brand Does Not Need Localisation

Global brand equity is valuable.

But brand equity does not eliminate the need for localisation.

A successful international company needs to know what should remain globally consistent and what should be adapted locally.

That may involve:

• Product positioning
• Advertising
• Language
• Packaging
• Promotions
• Influencer strategy
• Sales messaging
• Retail activation
• Customer education

The objective is not to abandon the global brand.

It is to make the global proposition commercially relevant locally.

This is particularly important for products where consumer trust, cultural relevance or professional endorsement influences purchasing decisions.

9. Expecting Results Too Quickly

One of the most damaging expectations international companies can bring to Africa is the belief that market entry should produce significant revenue within a few months.

Africa is not necessarily a difficult market.

It is often a market that requires relationship-building, adaptation and execution over time.

Establishing the right distributor.

Obtaining registrations.

Building retail coverage.

Educating customers.

Developing local partnerships.

Understanding procurement cycles.

Building brand awareness.

These activities take time.

Companies that enter with unrealistic short-term revenue expectations often make a predictable sequence of mistakes:

Low initial sales → management pressure → reduced investment → distributor disengagement → market exit.

The company then concludes that “Africa did not work.”

Often, the problem was not Africa.

The problem was the entry model.

The Bigger Mistake: Entering Africa Without a Market-Entry Architecture

The nine mistakes above have one common denominator.

Companies often approach Africa as a sales opportunity when they should be approaching it as a market-building exercise.

A successful entry strategy should connect several elements:

Market selection → Product-market fit → Regulatory pathway → Pricing → Distribution → Local partnerships → Commercial execution → Scale

If one of these components is fundamentally wrong, the entire expansion strategy can suffer.

For international FMCG and pharmaceutical companies, this is particularly important.

The African pharmaceutical market, for example, is increasingly influenced by local production, regulatory strengthening and supply-chain resilience. WHO estimates that African countries still import a very high proportion of finished pharmaceutical products, while governments and regional institutions are increasingly focused on strengthening local manufacturing capabilities.

That means the future opportunity is not simply about selling imported products into Africa.

It may increasingly involve:

• Local manufacturing
• Contract manufacturing
• Technology transfer
• Regional distribution
• Strategic partnerships
• Local sourcing
• Co-development
• Market-specific product portfolios

Companies that understand this shift early will be better positioned than those simply looking for an importer.

What International Companies Should Do Instead

Before committing significant capital to an African expansion, management should be able to answer seven questions:

1. Which country?

Not “Africa”. A specific market with a clear strategic rationale.

2. Which customer?

Define the actual customer segment rather than relying on broad population statistics.

3. Which product?

Determine whether the existing product requires adaptation.

4. Which route to market?

Understand how the product will actually reach the customer.

5. Which local partner?

Identify and independently assess the distributor, manufacturer, agent or strategic partner.

6. Which regulatory pathway?

Map registrations, approvals, compliance and timelines before committing resources.

7. What is the scale-up strategy?

Determine how the initial market can become a platform for broader regional expansion.

This is the difference between entering a market and building a business in a market.

Africa Rewards Preparation, Not Assumptions

The African opportunity is real.

But the opportunity should not be confused with simplicity.

The continent’s growth story will create significant opportunities for international companies in consumer goods, healthcare, pharmaceuticals, industrial products, technology and business services.

Yet the companies most likely to win will not necessarily be those with the largest budgets.

They will be those that understand the market deeply enough to make better decisions before they invest heavily.

Africa does not require international companies to abandon their global capabilities.

It requires them to combine those capabilities with local intelligence, disciplined market selection, strong partnerships and execution adapted to local realities.

The winning question is therefore not:

“How quickly can we enter Africa?”

It is:

“How intelligently can we build our position in Africa?”

That is where sustainable market entry begins.

About the Author

Jean Claude is a business consultant specialising in African market entry, product development, commercial strategy and business expansion, with a particular focus on helping international companies navigate the complexities of African markets.

His work sits at the intersection of product development and market execution—helping companies assess whether a product is commercially relevant for a target African market, determine how it should be positioned, and develop practical routes to market.

With experience across FMCG and pharmaceutical markets, Jean Claude works with businesses looking to move beyond theoretical market potential and understand the practical realities of entering, launching and scaling in Africa.

His approach combines market intelligence, product-market fit, partner identification, distributor assessment, regulatory considerations and commercial strategy to help international companies make better-informed expansion decisions.

Through Routrix Africa, he supports international and African businesses seeking to build commercially viable partnerships and navigate African markets with greater confidence.

His core belief is simple: Africa should not be approached as a single opportunity, but as a portfolio of markets that require the right strategy, the right partners and the right execution.

Strategic Takeaway

For international executives considering Africa, the most important investment may not be the first shipment, office or distribution agreement.

It is the quality of the decisions made before those investments are committed.

A well-designed market-entry strategy can prevent years of expensive trial and error.

Africa is open for business. But it rewards companies that come prepared.